These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2339009)

  • 21. The use and development of anxiolytics in Japan.
    Yamawaki S
    Eur Neuropsychopharmacol; 1999 Dec; 9 Suppl 6():S413-9. PubMed ID: 10622688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buspirone and related compounds as alternative anxiolytics.
    Taylor DP; Moon SL
    Neuropeptides; 1991 Jul; 19 Suppl():15-9. PubMed ID: 1679210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations of serotonin transmission in schizophrenia.
    Abi-Dargham A
    Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists.
    Pranzatelli MR
    Arch Neurol; 1994 Jun; 51(6):605-17. PubMed ID: 7515228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin revisited.
    Cowen PJ; Lucki I
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):167-9. PubMed ID: 21181118
    [No Abstract]   [Full Text] [Related]  

  • 26. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonergic anxiolytics and treatment of depression.
    Robinson DS; Alms DR; Shrotriya RC; Messina M; Wickramaratne P
    Psychopathology; 1989; 22 Suppl 1():27-36. PubMed ID: 2657837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 5-HT1A receptor agonists on patterns of rat motor activity in relation to effects on forebrain monoamine synthesis.
    Ahlenius S; Hillegaart V; Salmi P; Wijkström A
    Pharmacol Toxicol; 1993 Jun; 72(6):398-406. PubMed ID: 8361951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of carbamazepine treatment on pain threshold values and brain serotonin levels in rats.
    Pinelli A; Trivulzio S; Tomasoni L
    Pharmacology; 1997 Mar; 54(3):113-7. PubMed ID: 9127433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral studies of serotonin receptor agonists as antidepressant drugs.
    Lucki I
    J Clin Psychiatry; 1991 Dec; 52 Suppl():24-31. PubMed ID: 1684363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical pharmacological profile of migraine prophylactics of pizotifen type.
    Dlohozková N; Metys J; Valchár M; Soucek R
    Act Nerv Super (Praha); 1989 Dec; 31(4):300-1. PubMed ID: 2638122
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice.
    Kaur G; Kulkarni SK
    Brain Res; 2002 Jul; 943(2):206-15. PubMed ID: 12101043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT1A partial agonists. What is their future?
    Glitz DA; Pohl R
    Drugs; 1991 Jan; 41(1):11-8. PubMed ID: 1706983
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current concepts of the effects of neuroleptics].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
    [No Abstract]   [Full Text] [Related]  

  • 36. Antinociception in rat by sarpogrelate, a selective 5-HT(2A) receptor antagonist, is peripheral.
    Obata H; Saito S; Ishizaki K; Goto F
    Eur J Pharmacol; 2000 Sep; 404(1-2):95-102. PubMed ID: 10980267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of 5-HT2 receptor agonists with acetylcholine in spinal analgesic mechanisms in rats with neuropathic pain.
    Obata H; Saito S; Sasaki M; Goto F
    Brain Res; 2003 Mar; 965(1-2):114-20. PubMed ID: 12591127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1-aryl-4-[(1-tetralinyl)alkyl]piperazines: alkylamido and alkylamino derivatives. Synthesis, 5-HT1A receptor affinity, and selectivity. 3.
    Perrone R; Berardi F; Leopoldo M; Tortorella V; Fornaretto MG; Caccia C; McArthur RA
    J Med Chem; 1996 Aug; 39(16):3195-202. PubMed ID: 8759642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin-1A anxiolytics: an overview.
    Feighner JP; Boyer WF
    Psychopathology; 1989; 22 Suppl 1():21-6. PubMed ID: 2567039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
    Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
    Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.